Sero-prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) specific antibodies in dromedary camels in Tabuk, Saudi Arabia

被引:10
|
作者
Harrath, Rafik [1 ,2 ]
Abu Duhier, Faisel M. [1 ]
机构
[1] Univ Tabuk, Med Lab Technol Dept, Fac Appl Med Sci, Prince Fahd Bin Sultan Res Chair PFBSRC, Tabuk, Saudi Arabia
[2] Univ Monastir, Fac Pharm, Lab Communicable Dis & Biol Act Subst, Monastir, Tunisia
关键词
blood; Coronavirus; enzyme assays; immunoglobulin; reservoir; BATS;
D O I
10.1002/jmv.25186
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a novel Coronavirus which was responsible of the first case of human acute respiratory syndrome in the Kingdom of Saudi Arabia (KSA), 2012. Dromedary camels are considered as potential reservoirs for the virus and seem to be the only animal host which may transmit the infection to human. Further studies are required to better understand the animal sources of zoonotic transmission route and the risks of this infection. A primary sero-prevalence study of MERS-CoV preexisting neutralizing antibodies in Dromedary camel serum was conducted in Tabuk, western north region of KSA, in order to assess the seopositivity of these animals and to explain their possible role in the transmission of the infection to Human. One hundred seventy one (171) serum samples were collected from healthy dromedary camels with different ages and genders in Tabuk city and tested for specific serum IgG by ELISA using the receptor-binding S1 subunits of spike proteins of MERS-CoV. 144 (84,21%) of the total camel sera shown the presence of protein-specific antibodies against MERS-CoV. These results may provide evidence that MERS-CoV has previously infected dromedary camels in Tabuk and may support the possible role of camels in the human infection.
引用
收藏
页码:1285 / 1289
页数:5
相关论文
共 50 条
  • [32] Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations
    Abdel-Moneim, Ahmed S.
    [J]. ARCHIVES OF VIROLOGY, 2014, 159 (07) : 1575 - 1584
  • [33] Clinical spectrum of the Middle East respiratory syndrome coronavirus(MERS-CoV)
    Senga, Mikiko
    Arabi, Yaseen M.
    Fowler, Robert A.
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2017, 10 (02) : 191 - 194
  • [34] The discrepant epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV)
    MacIntyre C.R.
    [J]. Environment Systems and Decisions, 2014, 34 (3) : 383 - 390
  • [35] Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations
    Ahmed S. Abdel-Moneim
    [J]. Archives of Virology, 2014, 159 : 1575 - 1584
  • [36] Middle East respiratory syndrome coronavirus (MERS-CoV): Prevention in travelers
    Pavli, Androula
    Tsiodras, Sotirios
    Maltezou, Helena C.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2014, 12 (06) : 602 - 608
  • [37] Update: Recommendations for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    不详
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (27): : 557 - 557
  • [38] Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Perpetual Challenge
    Al Hajjar, Sami
    Memish, Ziad A.
    McIntosh, Kenneth
    [J]. ANNALS OF SAUDI MEDICINE, 2013, 33 (05) : 427 - 436
  • [39] Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
    Mostafa, Ahmed
    Kandeil, Ahmed
    Shehata, Mahmoud
    El Shesheny, Rabeh
    Samy, Abdallah M.
    Kayali, Ghazi
    Ali, Mohamed A.
    [J]. MICROORGANISMS, 2020, 8 (07) : 1 - 27
  • [40] Middle East respiratory syndrome coronavirus (MERS-Cov) screening of exposed healthcare workers in a tertiary care hospital in Saudi Arabia
    K Alameer
    B Abukhzam
    W Khan
    A El-Saed
    H Balkhy
    [J]. Antimicrobial Resistance and Infection Control, 4 (Suppl 1)